LLY Eli Lilly

Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.

$184.49  +1.88 (1.03%)
As of 04/09/2021 16:05:16 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  USA
Country of incorporation:  USA
IPO date:  02/26/2001
Outstanding shares:  958,992,159
Average volume:  3,907,492
Market cap:   $176,924,463,414
Current dividend yield:  1.65%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    532457108
ISIN:        US5324571083
Sedol:      2516152
Valuation   (See tab for details)
PE ratio:   28.57
PB ratio:   29.65
PS ratio:   7.21
Return on equity:   109.79%
Net income %:   25.24%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy